APT Medical Inc
SSE:688617
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (46.7), the stock would be worth ¥329.73 (39% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 33.7 | ¥237.87 |
0%
|
| 3-Year Average | 46.7 | ¥329.73 |
+39%
|
| 5-Year Average | 47.8 | ¥337.3 |
+42%
|
| Industry Average | 19.5 | ¥137.78 |
-42%
|
| Country Average | 18.3 | ¥128.95 |
-46%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
A
|
APT Medical Inc
SSE:688617
|
33.5B CNY | 33.7 | 38.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
162.5B USD | 53.6 | 56.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
157.7B USD | 16.5 | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 23.9 | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
103.9B USD | 14.3 | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
85.4B USD | 18.8 | 24 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 30.4 | 44.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 13 | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 37.8 | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.4B USD | 12.5 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.1B USD | 16.3 | 21 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 9.8 |
| Median | 18.3 |
| 70th Percentile | 36.5 |
| Max | 266 666.7 |
Other Multiples
APT Medical Inc
Glance View
APT Medical Inc. is a company embedded in the intricate world of medical devices, specializing in the development, production, and distribution of cardiovascular and peripheral vascular medical products. The company’s foundation rests on its ability to innovate and provide solutions that address the complex challenges faced by healthcare professionals in the treatment of heart and vascular diseases. APT Medical strategically focuses on minimally invasive technologies, which are increasingly preferred for their reduced patient recovery times and overall improvement in procedural success rates. By keeping its pulse on the evolving demands within the healthcare sector, APT Medical efficiently aligns its research and development initiatives to meet the global standards and expectations. Revenue streams for APT Medical Inc. flow primarily from its broad portfolio of interventional medical devices, such as guidewires, balloon catheters, and vascular closure devices. The intricacy of their manufacturing processes, coupled with stringent regulatory requirements, ensures that their offerings are both high in quality and competitively priced. Through a network of strategic partnerships, distribution channels, and a robust export framework, the company extends its reach across several international markets. By maintaining a keen focus on customer service and post-market support, APT Medical not only thrives on initial sales but also secures a steady stream of revenue from recurring purchases and long-term partnerships with healthcare institutions globally.